Article
Replication of PTPRC as genetic biomarker of response to TNF inhibitors in patients with rheumatoid arthritis.
The pharmacogenomics journal - 1 Apr 2016
Ferreiro-Iglesias A, Montes A, Perez-Pampin E, Cañete J D, Raya E, Magro-Checa C, Vasilopoulos Y, Sarafidou T, Caliz R, Ferrer M A, Joven B, Carreira P, Balsa A, Pascual-Salcedo D, Blanco F J, Moreno-Ramos M J, Fernández-Nebro A, Ordóñez M C, Alegre-Sancho J J, Narváez J, Navarro-Sarabia F, Moreira V, Valor L, García-Portales R, Marquez A, Martin J, Gómez-Reino J J, Gonzalez A
Abstract excerpt
Genetic biomarkers could be useful for orienting treatment of patients with rheumatoid arthritis (RA), but none has been convincingly validated yet. Putative biomarkers include 14 single nucleotide polymorphisms that have shown association with response to TNF inhibitors (TNFi) in candidate gene studies and that we assayed here in 755 RA patients. Three of them, in the PTPRC, IL10 and CHUK genes, were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
